This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kass' Q&A Left Me Wanting More

The next unchallenged Kassism: "I'm also short Berkshire because the salad days for insurance, which is the cornerstone of Berkshire's business, are over."

I have a one-word retort: Geico. But more importantly, I want to know why the reporter didn't. It's a very good insurance play long-term and, uh, is car insurance wilted lettuce?

Not to mention that at the most recent annual meeting, Buffett spoke about the company's recent success insuring municipal bonds. It's a little different, but aren't companies like MBIA (MBI - Get Report) and Ambac (ABK) using Buffett to insure them? Are those salad days over ... before they even really began? We won't know, because if the question was asked, the answer wasn't shared.

Anyhow, Kass is soon off talking about Buffett's exposure to the housing downturn through Clayton Holdings (CLAY). But instead of the journalist noting, for the savvy investor's benefit, that Clayton is but a pimple in Bekshire's vast stable of holdings, the conversation then turns toward Kass' shorts in the dental industry.

Anyhow, there are concerns about the fact that Buffett can't work or live forever. But that is no secret and has probably been priced into the stock. In fact, it's probably another reason for the narrowing outperformance, which, again, is no reason to short. What is probably not priced in is the fact that his successor might be decent. And the potential for upside surprise is not what you should look for in a short.

Anyhow, Doug is normally my man. And he talks about shorting more than Berkshire. He recommends everything from Colgate-Palmolive (CL - Get Report) to Target (TGT - Get Report) to Danaher (DHR - Get Report), which Doug says he considers a dental company. But no matter the wisdom of the interviewee or the merits of the underlying ideas, which Doug spells out in more detail here, beware and be aware anytime you see ideas set forth in a question and answer format.
At the time of publication, Fuchs had no positions in any of the stocks mentioned in this column.

Marek Fuchs was a stockbroker for Shearson Lehman Brothers and a money manager before becoming a journalist who wrote The New York Times' "County Lines" column for six years. He also did back-up beat coverage of The New York Knicks for the paper's Sports section for two seasons and covered other professional and collegiate sports. He has contributed frequently to many of the Times' other sections, including National, Metro, Escapes, Style, Real Estate, Arts & Leisure, Travel, Money & Business, Circuits and the Op-Ed Page. For his "Business Press Maven? column on how business and finance are covered by the media, Fuchs was named best business journalist critic in the nation by the Talking Biz website at The University of North Carolina School of Journalism and Mass Communication. Fuchs is a frequent speaker on the business media, in venues ranging from National Public Radio to the annual conference of the Society of American Business Editors and Writers. Fuchs appreciates your feedback; click here to send him an email.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BRK.A $202,531.00 -1.37%
CL $62.81 -0.85%
DHR $87.02 -1.18%
MBI $7.02 4.46%
TGT $77.71 -0.41%

Markets

Chart of I:DJI
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASDAQ 4,776.5080 -51.8170 -1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs